Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity

Atherosclerosis

Volumn 150, Issue 1, 2000, Pages 129-134

  Arrol, Sharon ^a,b   Mackness, Michael I ^a   Durrington, Paul N ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b Institute for Diagnostic Research   (United States)

Author keywords

Cholesteryl ester transfer activity; Lipoprotein oxidation; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID PEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; IN VITRO STUDY; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION;

ADULT; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; VITAMIN E;

EID: 0034186642     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00353-6     Document Type: Article

References (37)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JC. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenity. New Engl J Med 1989;320:915-24.
2. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously increased with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 1981;78:6499-503.
3. Leake DS, Rankin SM. The oxidative modification of low-density lipoproteins by macrophages. Biochem J 1990;270:741-8.
4. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1980;74:1890-4.
5. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophages, and smooth muscle cell content. Br Heart J 1993;69:377-81.
6. De Graaf J, Hak-Lemmers H, Hectors M, Demacker P, Hendriks J, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein sub-fraction in healthy subjects. Arterioscler Thromb 1991;11:298-306.
7. Chait A, Brazg R, Tribble D, Krauss R. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype pattern B. Am J Med 1993;94:350-6.
8. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM. LDL subclass phenotypes and the insulin resistance syndrome. Circulation 1993;88:318-87.
9. Editorial. Cholesteryl ester transfer protein, Lancet 1991;338:666-667.
10. Bhatnagar D, Durrington PN, Channon KM, Prais HR, Mackness MI. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 1993;98:25-32.
11. Bhatnagar D, Kumar S, Mackness MI, Durrington PN. Plasma lipoprotein composition and cholesteryl ester transfer form high density lipoproteins to very low density lipoproteins in patients with non-insulin dependent diabetes mellitus. Diab Med 1996;13:139-44.
12. Barter P, Rye K-A. Cholesteryl ester transfer protein: its role in plasma lipid transport. Clin Exp Pharm Physiol 1994;21:663-72.
13. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, et al. Increased high density lipoprotein caused by a common cholesteryl ester transfer protein gene mutation. New Engl J Med 1990;323:1324-38.
14. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR. Increased coronary heart disease in Japanese American men with mutations in the cholesteryl ester transfer gene despite increased HDL levels. J Clin Invest 1996;97:2917-23.
15. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Kniff P, McPherson R, Bruschke AVG, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. New Engl J Med 1998;338:86-93.
16. Marotti KR, Castle CK, Boyle TP, Li AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice overexpressing simian cholesteryl ester transfer protein. Nature 1993;364:73-5.
17. Plump AS, Masucci-Magoules L, Bruce C, Bisgaier CL, Breslow JL, Tall AR. Increased atherosclerosis in apo E and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler Thromb Vase Biol 1999;19:1105-10.
18. Hayek T, Masucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR. Decreased early atherosclerotic lesions in hypertriglyceridaemic mice expressing cholesterol ester transfer protein transgene. J Clin Invest 1995;96:2701-4.
19. Salonen JT, Salonen R, Penttila I, Herranen J, Jauhiainen M, Kantola M, Lappetelainen R, Maenpaa PH, Alfthan G, Puska P. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985;56:226-31.
20. Bowry VW, Stanley KK, Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 1992;89:10316-20.
21. Mackness MI, Abbott CA, Arrol S, Durrington PN. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 1993;29:829-34.
22. Walldius G, Erikson U, Olsson AG, Bergstrand I, Hadell K, Johansson J, Kaijser L, Lassvik C, Molgaard J, Nilsson S. The effect of probucol on femerol atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 1994;74:875-83.
23. Franceschini G, Chiesa G, Sirtori E. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients. Eur J Clin Invest 1991;21:384-8.
24. Bagdade JD, Kaufman D, Ritter MC, Subaiah PV, et al. Probucol treatment in hypercholesterolaemic patients: effects on lipoprotein composition, HDL particle size, and cholesteryl ester transfer. Atherosclerosis 1990;84:145.
25. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
26. Rapola JM, Virtamo J, Huttunen JIC, Albanes D, Taylor PR, Heinonen OP. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715-20.
27. Mackness MI, Durrington PN. In: Converse CA, Skinner ER, editors. Lipoprotein Analysis: A Practical Approach. Oxford: IRL Press, 1992:1-42.
28. Adolphson JL, Albers JJ. Comparison of two commercial nephelometric methods for the apoprotein A-I and apoprotein B with standardised apoprotein A-I and B radioimmunoassays. J Lipid Res 1989;30:597-606.
29. Esterbauer H, Striegel H, Puhl H, Rotherneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 1989;6:6775.
30. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens GA. Spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;30:627-30.
31. Thurnham DI, Smith E, Flora PS. Concurrent liquid-chromatographic assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene, and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 1988;34:377-81.
32. Channon KM, Clegg RJ, Bhatnagar D, Ishola M, Arrol S, Durrington PN. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis 1990;8:217-26.
33. Durrington PN, Miller JP. Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia. Atherosclerosis 1985;55:187-94.
34. Atmeh RF, Stewart JM, Boag DE, Packard CJ, Lorimer AR, Shepherd J. The hypolipidaemic action of probucol: a study of its effect on high and low density lipoproteins. J Lipid Res 1983;24:588-95.
35. The α-Tocopherol, β-Carotene Cancer Prevention Study Group. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994;330:1029-35.
36. Jialal I. Evolving lipoprotein risk factors: lipoprotein (a) and oxidised low-density lipoprotein. Clin Chem 1998;44:1827-32.
37. Morel DW. Reduced cholesterol efflux to mildly oxidised high density lipoprotein. Biochem Biophys Res Comm 1994;200:408 16.